Oscar Health, Inc. (OSCR) Income Statement
OSCR 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsOSCR revenue and net income
Where OSCR's revenue goes
2025Each bar shows an amount and its share of revenue. OSCR kept −3.8% of revenue as net income.
OSCR profit margins
OSCR growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +27.5% | +41.6% | +81.8% | — |
| Gross profit | −8.8% | −25.8% | +23.3% | — |
| Operating income | −792.1% | — | — | — |
| Net income | −1,842.5% | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
OSCR quarterly EPS vs estimates
Oscar Health beat the analyst EPS estimate in 4 of the last 8 quarters. Next report: November 5, 2026 (estimate $-0.11).
OSCR income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $4.13B | $1.92B | $589.6M | $553.8M |
| Cost of revenue | $10.02B | $7.33B | $4.64B | $0 | $0 | $0 | $0 |
| Gross profit | $1.68B | $1.84B | $5.86B | $4.13B | $1.92B | $589.6M | $553.8M |
| Sales, general & admin | $2.05B | $1.76B | $405.5M | $1.42B | $265.1M | $166.7M | $110.7M |
| Total operating expenses | $2.08B | $1.79B | $6.10B | $4.74B | $2.49B | $995.4M | $813.2M |
| Operating income | −$396.4M | $57.3M | −$235.6M | −$610.1M | −$570.6M | −$405.8M | −$259.4M |
| Interest income | — | — | — | $31.3M | $10.2M | $8.0M | $11.1M |
| Interest expense | $17.6M | $23.7M | $24.6M | $22.6M | $4.7M | $3.5M | $0 |
| Income before taxes | −$437.3M | $33.4M | −$267.3M | −$610.1M | −$570.6M | −$405.8M | −$259.4M |
| Income taxes | $5.6M | $7.3M | $3.3M | −$523,000 | $846,000 | $1.0M | $1.8M |
| Net income | −$443.2M | $25.4M | −$270.7M | −$606.3M | −$572.6M | −$406.8M | −$261.2M |
| EBITDA | −$391.1M | $89.3M | −$235.6M | −$572.2M | −$551.3M | −$391.0M | −$252.5M |
| EPS (diluted) | −$1.74 | −$0.02 | −$1.20 | −$2.85 | −$3.07 | −$1.22 | −$9.01 |
| Gross margin | 14.4% | 20.1% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating margin | −3.4% | 0.6% | −4.0% | −14.8% | −29.7% | −68.8% | −46.8% |
| Net margin | −3.8% | 0.3% | −4.6% | −14.7% | −29.8% | −69.0% | −47.2% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.88B | $4.65B | $2.81B | $2.99B | $2.86B | $3.05B | $2.39B | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B |
| Cost of revenue | $0 | $3.23B | $2.62B | $2.59B | $2.55B | $2.26B | $2.07B | $0 | $0 | −$1 | $976,000 | −$30,000 |
| Gross profit | $4.88B | $1.42B | $185.2M | $399.7M | $311.0M | $786.6M | $327.3M | $2.42B | $2.22B | $2.14B | $1.43B | $1.44B |
| Sales, general & admin | $176.9M | $160.1M | $511.0M | $521.6M | $534.5M | $482.8M | $466.6M | $459.5M | $435.1M | $394.7M | $85.6M | $325.8M |
| Total operating expenses | $4.50B | $713.3M | $518.9M | $528.9M | $541.5M | $489.5M | $475.1M | $2.48B | $2.16B | $1.96B | $1.58B | $1.50B |
| Operating income | $383.0M | $704.1M | −$333.7M | −$129.2M | −$230.5M | $297.1M | −$147.7M | −$52.3M | $60.9M | $178.5M | −$150.6M | −$64.8M |
| Interest income | — | — | — | $231,000 | — | — | — | $1.6M | — | — | — | $1.7M |
| Interest expense | $4.7M | $5.4M | $1.1M | $6.9M | $5.8M | $6.0M | $6.0M | $5.8M | $6.0M | $5.9M | $6.2M | $6.1M |
| Income before taxes | $383.0M | $698.8M | −$352.7M | −$139.3M | −$233.5M | $288.2M | −$153.7M | −$52.3M | $60.9M | $178.5M | −$150.6M | −$64.8M |
| Income taxes | $21.2M | $19.8M | −$247,000 | −$1.8M | −$5.0M | $12.7M | −$404,000 | $2.1M | $4.6M | $996,000 | −$806,000 | $915,000 |
| Net income | $361.8M | $679.0M | −$352.6M | −$137.4M | −$228.4M | $275.3M | −$153.5M | −$54.6M | $56.2M | $177.4M | −$150.0M | −$65.4M |
| EBITDA | $393.8M | $711.1M | −$346.1M | −$125.1M | −$220.7M | $300.9M | −$138.4M | −$39.0M | $74.5M | $192.2M | −$136.7M | −$49.5M |
| EPS (diluted) | $1.10 | $2.07 | −$1.24 | −$0.53 | −$0.89 | $0.92 | −$0.62 | −$0.22 | $0.20 | $0.62 | −$0.66 | −$0.29 |
| Gross margin | 100.0% | 30.5% | 6.6% | 13.4% | 10.9% | 25.8% | 13.7% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating margin | 7.8% | 15.2% | −11.9% | −4.3% | −8.0% | 9.8% | −6.2% | −2.2% | 2.7% | 8.3% | −10.5% | −4.5% |
| Net margin | 7.4% | 14.6% | −12.6% | −4.6% | −8.0% | 9.0% | −6.4% | −2.3% | 2.5% | 8.3% | −10.5% | −4.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in OSCR's financial statements (latest annual report filed February 13, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
OSCR financial results
In fiscal year 2025 (ended December 31, 2025), Oscar Health reported revenue of $11.7 billion, up 27.5% from the year before. It had a net loss of $443.2 million, a net profit margin of −3.8%. Diluted earnings per share came to −$1.74. Over five years revenue grew at an average rate of 81.8% a year.
See the OSCR stock overview for the latest quote and news, or the OSCR chart for price history and technical indicators.
OSCR income statement FAQ
What is Oscar Health's annual revenue?
Oscar Health reported total revenue of $11.7 billion for fiscal year 2025, which ended on December 31, 2025. That was up 27.5% from $9.2 billion the previous year.
Is Oscar Health profitable?
No. Oscar Health reported a net loss of $443.2 million in fiscal 2025, a net profit margin of −3.8%; its operating margin was −3.4%.
What is Oscar Health's gross margin?
Oscar Health's gross margin was 14.4% in fiscal 2025: for every $100 of revenue, Oscar Health kept $14 after the direct cost of its products and services.
How fast is Oscar Health growing?
Revenue grew 81.8% a year on average over the last five fiscal years, from $589.6 million to $11.7 billion.
What are Oscar Health's earnings per share?
Oscar Health earned $-1.74 per diluted share in fiscal 2025, compared with $-0.02 a year earlier.
When will Oscar Health report its next earnings?
Oscar Health is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 before the market opens.
When does Oscar Health's fiscal year end?
Oscar Health's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 13, 2026.